BIODESIX, INC. Payments of Debt Issuance Costs
BIODESIX, INC. (BDSX) reported Payments of Debt Issuance Costs of $39.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-05
- BIODESIX, INC. payments of debt issuance costs for the quarter ending 2026-06-30 was $11.00K, a 31.25% decline year-over-year.
- BIODESIX, INC. payments of debt issuance costs for the quarter ending 2026-03-31 was $28.00K, a 154.55% increase year-over-year.
- BIODESIX, INC. payments of debt issuance costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- BIODESIX, INC. payments of debt issuance costs for the quarter ending 2025-09-30 was $3.00K, a 200.00% increase year-over-year.
- BIODESIX, INC. payments of debt issuance costs for fiscal 2025 was $30.00K, a 31.82% decline from fiscal 2024.
- BIODESIX, INC. payments of debt issuance costs for fiscal 2024 was $44.00K, a 94.72% decline from fiscal 2023.
- BIODESIX, INC. payments of debt issuance costs for fiscal 2023 was $833.00K, a 77.64% decline from fiscal 2022.
- BIODESIX, INC. payments of debt issuance costs for fiscal 2022 was $3.73M, a 2171.34% increase from fiscal 2021.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $39.00K 10-Q · filed 2026-08-05 | $39.00K derived: sum of 3 quarters · filed 2026-08-05 | $42.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $28.00K 10-Q · filed 2026-05-04 | $28.00K derived: sum of 2 quarters · filed 2026-05-04 | $31.00K derived: sum of 3 quarters · filed 2026-05-04 | $47.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.00K derived: sum of 2 quarters · filed 2026-02-26 | $19.00K derived: sum of 3 quarters · filed 2026-08-05 | $30.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $19.00K derived: sum of 2 quarters · filed 2026-08-05 | $30.00K 10-Q · filed 2025-11-03 | $36.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $27.00K 10-Q · filed 2026-08-05 | $33.00K derived: sum of 3 quarters · filed 2026-08-05 | $34.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $11.00K 10-Q · filed 2026-05-04 | $17.00K derived: sum of 2 quarters · filed 2026-05-04 | $18.00K derived: sum of 3 quarters · filed 2026-05-04 | $37.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.00K derived: sum of 2 quarters · filed 2026-02-26 | $26.00K derived: sum of 3 quarters · filed 2026-02-26 | $44.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $20.00K derived: sum of 2 quarters · filed 2025-11-03 | $38.00K 10-Q · filed 2025-11-03 | $38.00K derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $37.00K 10-Q · filed 2025-08-07 | $37.00K derived: sum of 3 quarters · filed 2025-08-07 | $38.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $18.00K 10-Q · filed 2025-05-13 | $18.00K derived: sum of 2 quarters · filed 2025-05-13 | $19.00K derived: sum of 3 quarters · filed 2025-05-13 | $50.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.00K derived: sum of 2 quarters · filed 2025-03-03 | $32.00K derived: sum of 3 quarters · filed 2025-03-03 | $833.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $32.00K derived: sum of 2 quarters · filed 2024-11-01 | $833.00K 10-Q · filed 2024-11-01 | $2.31M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $832.00K 10-Q · filed 2024-08-07 | $2.31M derived: sum of 3 quarters · filed 2024-08-07 | $2.44M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $801.00K 10-Q · filed 2024-05-08 | $2.28M derived: sum of 2 quarters · filed 2024-05-08 | $2.41M derived: sum of 3 quarters · filed 2024-05-08 | |
| 2022-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $1.61M derived: sum of 2 quarters · filed 2024-03-01 | $3.73M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.25M 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $2.12M 10-Q · filed 2023-08-07 | |||
| 2021-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $55.00K derived: sum of 2 quarters · filed 2023-03-06 | $56.00K derived: sum of 3 quarters · filed 2023-03-06 | $164.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$12.00K derived: sum of 2 quarters · filed 2022-11-03 | $96.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $109.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $108.00K 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |